Table 2.
Details of pelvic evaluation*
| Characteristic | All (115) | URA (84) | MCDK (31) | Age < 10 (11) | Age < 10 with URA (7) | Age < 10 with MCDK (4) | Age ≥ 10 (104) | Age ≥ 10 with URA (77) | Age ≥ 10 with MCDK (27) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Pelvic evaluation | ||||||||||
| Uterine MA | 29 (25%) | 22 (26%) | 7 (22%) | 6 (55%) | 4 (57%) | 2 (50%) | 23 (22%) | 18 (23%) | 5 (19%) | |
| Vaginal MA | 2 (2%) | 2 (2%) | 1 (9%) | 1 (14%) | 1 (1%) | 1 (1%) | ||||
| Combined uterine/vaginal MA | 29 (25%) | 26 (31%) | 3 (10%) | 1 (9%) | 1 (14%) | 28 (27%) | 25 (33%) | 3 (11%) | ||
| No MA | 55 (48%) | 34 (41%) | 21 (68%) | 3 (27%) | 1 (14%) | 2 (50%) | 52 (50%) | 33 (43%) | 19 (70%) | |
| Type of pelvic evaluation | ||||||||||
| Ultrasound | 84 (73%) | 60 (71%) | 24 (77%) | 9 (82%) | 6 (86%) | 3 (75%) | 75 (72%) | 54 (70%) | 21 (78%) | |
| CT | 37 (32%) | 31 (37%) | 6 (19%) | 37 (36%) | 31 (40%) | 6 (22%) | ||||
| MRI | 40 (35%) | 33 (39%) | 7 (23%) | 4 (36%) | 2 (29%) | 2 (50%) | 36 (35%) | 31 (40%) | 5 (19%) | |
| Surgery | 4 (3%) | 3 (4%) | 1 (3%) | 1 (9%) | 1 (14%) | 3 (3%) | 2 (3%) | 1 (4%) | ||
| Unknown | 4 (3%) | 4 (5%) | 1 (9%) | 1 (14%) | 3 (3%) | 3 (4%) | ||||
| Indication for pelvic evaluation | ||||||||||
| Routine screening | 1 (1%) | 1 (3%) | 1 (1%) | 1 (4%) | ||||||
| Abdominal pain/dysmenorrhea | 40 (35%) | 33 (39%) | 7 (2%) | 40 (38%) | 33 (43%) | 7 (26%) | ||||
| Abnormal uterine bleeding | 12 (10%) | 12 (14%) | 12 (12%) | 12 (16%) | ||||||
| Finding on renal ultrasound | 11 (10%) | 4 (5%) | 7 (2%) | 4 (36%) | 1 (14%) | 3 (75%) | 7 (7%) | 3 (4%) | 4 (15%) | |
| Finding during other work up | 15 (13%) | 13 (15%) | 2 (6%) | 4 (36%) | 4 (57%) | 11 (11%) | 9 (12%) | 2 (7%) | ||
| Pregnancy | 4 (3%) | 3 (4%) | 1 (3%) | 4 (4%) | 3 (4%) | 1 (4%) | ||||
| Primary amenorrhea | 8 (7%) | 6 (7%) | 2 (6%) | 8 (8%) | 6 (8%) | 2 (7%) | ||||
| Finding during surgery | 2 (2%) | 2 (2%) | 2 (2%) | 2 (3%) | ||||||
| Physical exam | 8 (7%) | 7 (8%) | 1 (3%) | 2 (18%) | 2 (29%) | 6 (6%) | 5 (6%) | 1 (4%) | ||
| Infertility evaluation | 1 (1%) | 1 (1%) | 1 (1%) | 1 (1%) | ||||||
| Other | 21 (18%) | 10 (12%) | 11 (35%) | 1 (9%) | 1 (25%) | 20 (19%) | 10 (13%) | 10 (37%) | ||
*Some patients underwent > 1 form of pelvic evaluation and/or had > 1 indication for pelvic evaluation